| Celgene Corporation - SWOT Analysis company | | | | regulation. The company primarily operates in the US. |
| profile is the essential source for top-level company | | | | The company is headquartered in Summit, New |
| data and information. Celgene Corporation - SWOT | | | | Jersey and employed 2,441 people as of December |
| Analysis examines the company's key business | | | | 2008. The company recorded revenues of $2,254.8 |
| structure and operations, history and products, and | | | | million during the financial year (FY) ended December |
| provides summary analysis of its key revenue lines | | | | 2008, an increase of 60.4% over FY2007. The |
| and strategy. | | | | operating loss of the company was $1,464.2 million |
| Celgene, an integrated biopharmaceutical company, | | | | during FY2008, as compared with an operating profit |
| discovers, develops and commercializes novel | | | | of $425.1 million in FY2007. The net loss was $1,533.7 |
| therapies for the treatment of cancer and | | | | million in FY2008, as compared with a net profit of |
| inflammatory diseases through gene and protein | | | | $226.4 million in FY2007. |